Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Gestational Trophoblastic Disease Global Market Report 2025
Request Sample Buy Now
Global Gestational Trophoblastic Disease Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Gestational Trophoblastic Disease Global Market Report 2025

By Type (Hydatidiform Mole, Choriocarcinoma, Placental-Site Trophoblastic Tumor, Epithelioid Trophoblastic Tumor, Other Types), By Treatment (Surgery, Chemotherapy, Suction Dilation And Curettage (D&C), Radiation Therapy), By End User (Hospital And Clinics, Diagnostic Centers, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gestational Trophoblastic Disease Market Overview

• Gestational Trophoblastic Disease market size has reached to $2.06 billion in 2024

• Expected to grow to $2.63 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%

• Growth Driver: Rising Incidence Of Abnormal Pregnancies Fuels Growth In The Gestational Trophoblastic Disease Market

• Market Trend: Innovative Guidelines Enhance Care In The Gestational Trophoblastic Disease Market

• Asia-Pacific was the largest region in 2024.

What Is Covered Under Gestational Trophoblastic Disease Market?

Gestational trophoblastic disease (GTD) refers to a group of rare and abnormal conditions that develop from the abnormal growth of trophoblastic cells that develop a tumor inside the uterus after conception. The treatment of GTD involves uterine evacuation and monitoring human chorionic gonadotropin (hCG) levels.

The main types of gestational trophoblastic disease are hydatidiform mole, choriocarcinoma, placental-site trophoblastic tumor, epithelioid trophoblastic tumor, and others. A hydatidiform mole, also known as a molar pregnancy, is a rare and abnormal pregnancy condition. This condition can be treated with surgery, chemotherapy, suction dilation and curettage (D&C), and radiation therapy by various end-users such as hospitals, clinics, diagnostic centers, and others.

Gestational Trophoblastic Disease Market Size and growth rate 2025 to 2029: Graph

What Is The Gestational Trophoblastic Disease Market Size 2025 And Growth Rate?

The gestational trophoblastic disease market size has grown strongly in recent years. It will grow from $2.06 billion in 2024 to $2.16 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to public health initiatives, improved understanding of disease pathology, medical research and clinical trials, development of targeted therapies, shift in treatment protocols.

What Is The Gestational Trophoblastic Disease Market Growth Forecast?

The gestational trophoblastic disease market size is expected to see steady growth in the next few years. It will grow to $2.63 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to healthcare infrastructure development, enhanced telemedicine and remote care, patient-centric care approaches, regulatory approvals for novel treatments, genomic and molecular studies. Major trends in the forecast period include shift towards personalized medicine, advancements in molecular diagnostics, focus on immunotherapies and targeted therapies, integration of digital health technologies, rising awareness and education programs.

The forecast of 5.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of methotrexate formulations and Human Chorionic Gonadotropin test kits(hCG test kits) sourced from India and Germany, exacerbating rare pregnancy complication management costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Gestational Trophoblastic Disease Market Segmented?

1) By Type: Hydatidiform Mole, Choriocarcinoma, Placental-Site Trophoblastic Tumor, Epithelioid Trophoblastic Tumor, Other Types

2) By Treatment: Surgery, Chemotherapy, Suction Dilation And Curettage (D&C), Radiation Therapy

3) By End User: Hospital And Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Hydatidiform Mole: Complete Hydatidiform Mole, Partial Hydatidiform Mole

2) By Choriocarcinoma: Non-Metastatic Choriocarcinoma, Metastatic Choriocarcinoma

3) By Placental-Site Trophoblastic Tumor: PSTT With Normal Placentation, PSTT With Abnormal Placentation

4) By Epithelioid Trophoblastic Tumor: Epithelioid Trophoblastic Tumor With No Evidence Of Metastasis, Epithelioid Trophoblastic Tumor With Metastasis

5) By Other Types: Trophoblastic Tumor Of Unknown Origin, Non-Gestational Trophoblastic Neoplasia

What Is Driving The Gestational Trophoblastic Disease Market? Rising Incidence Of Abnormal Pregnancies Fuels Growth In The Gestational Trophoblastic Disease Market

The growth in abnormal pregnancies is expected to propel the growth of the gestational trophoblastic disease market going forward. Abnormal pregnancies refer to pregnancies that deviate from the typical or expected course and may pose risks to the health of the mother, the fetus, or both. In abnormal pregnancies, such as molar pregnancies, the trophoblast develops into a tumor instead of a fetus, resulting in gestational trophoblastic disease. For instance, in May 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, in 2022, there were 251,377 abortions for women residing in England and Wales—the highest number recorded since the Abortion Act was introduced, marking a 17% increase from the previous year. Therefore, the growth in abnormal pregnancies is driving the gestational trophoblastic disease industry.

What Is Driving The Gestational Trophoblastic Disease Market? Impact Of Increasing Cigarette Smoking On The Growth Of The Gestational Trophoblastic Disease Market

The increasing cigarette smoking is expected to propel the growth of the gestational trophoblastic disease market going forward. Cigarette smoking refers to the practice of burning tobacco and inhaling the resulting smoke, which contains various chemicals and toxins that can cause detrimental effects on different structures of the body. Smoking may damage the DNA of trophoblastic cells, which are responsible for forming the placenta, which may lead to abnormal growth and division of these cells, resulting in gestational trophoblastic disease. For instance, in May 2022, according to the Australian Bureau of Statistics, an Australia-based government administration, the rate of daily smokers increased with age, peaking at 13.6% in the 55–64 age group during 2021–2022. Therefore, the increasing cigarette smoking is driving the gestational trophoblastic disease industry.

Who Are The Major Players In The Global Gestational Trophoblastic Disease Market?

Major companies operating in the gestational trophoblastic disease market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Novartis AG, Merck And Co. Inc., Sun Pharmaceutical Industries Ltd., GSK PLC, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Mylan N.V, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Perrigo Company PLC, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., Wockhardt Ltd., Natco Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Arog Pharmaceuticals Inc., Advenchen Laboratories LLC., Mendus AB, AB Science S.A.

What Are The Key Trends Of The Global Gestational Trophoblastic Disease Market? Innovative Guidelines Enhance Care In The Gestational Trophoblastic Disease Market

Major companies operating in the gestational trophoblastic disease market are introducing guidelines to provide reliable services to customers. The launch of the updated guideline ensures a comprehensive review of current diagnostic and management strategies for patients with GTD. It provides doctors and nurses with the necessary information to achieve excellence in the care of these patients. For instance, in May 2022, the Health Service Executive (HSE) National Cancer Control Programme (NCCP), an Ireland-based provider of public health and social care services, launched the updated gestational trophoblastic disease (GTD) guideline at the European organization for the treatment of trophoblastic disease. This guideline integrates the best current research evidence with clinical expertise and patient values. It aims to reduce variation in practice and improve the quality of care delivered to patients.

What Are The Key Trends Of The Global Gestational Trophoblastic Disease Market? Innovative Reproductive Tissue Preservation Solutions In The Gestational Trophoblastic Disease Market

Major companies operating in the gestational trophoblastic disease market are developing innovative treatments, such as reproductive tissue preservation solutions, to provide reliable services to customers. A reproductive tissue preservation solution preserves the viability of reproductive tissue, such as sperm, eggs, embryos, and ovarian tissue, typically composed of a mixture of cryoprotectants that help to protect cells from the damage caused by freezing. For instance, in June 2022, Inception Fertility LLC, a US-based fertility care provider, launched HavenCryo, a long-term reproductive tissue and cryopreservation storage solution. HavenCryo offers a unique experience for fertility providers and patients by storing reproductive tissue, including oocytes (eggs), sperm, and embryos, for an indefinite time. This gives patients more family-building flexibility, peace of mind, and control over their reproductive choices. HavenCryo can store eggs or embryos for women diagnosed with gestational trophoblastic disease (GTD) and need to undergo treatment that could damage their fertility.

Need data on a specific region in this market?
Request Customisation

Regional Outlook For The Global Gestational Trophoblastic Disease Market

Asia-Pacific was the largest region in the gestational trophoblastic disease market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Gestational Trophoblastic Disease Market?

The gestational trophoblastic disease market consists of revenues earned by entities by providing services such as gynecology services, oncology services, and surgical services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gestational trophoblastic disease market also includes sales of medications, diagnostic tools, laboratory tests, methotrexate, etoposide, cyclophosphamide, and vincristine. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gestational Trophoblastic Disease Industry?

The gestational trophoblastic disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gestational trophoblastic disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Gestational Trophoblastic Disease Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.16 billion
Revenue Forecast In 2034 $2.63 billion
Growth Rate CAGR of 5.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Hydatidiform Mole, Choriocarcinoma, Placental-Site Trophoblastic Tumor, Epithelioid Trophoblastic Tumor, Other Types
2) By Treatment: Surgery, Chemotherapy, Suction Dilation And Curettage (D&C), Radiation Therapy
3) By End User: Hospital And Clinics, Diagnostic Centers, Other End Users Subsegments: 1) By Hydatidiform Mole: Complete Hydatidiform Mole, Partial Hydatidiform Mole
2) By Choriocarcinoma: Non-Metastatic Choriocarcinoma, Metastatic Choriocarcinoma
3) By Placental-Site Trophoblastic Tumor: PSTT With Normal Placentation, PSTT With Abnormal Placentation
4) By Epithelioid Trophoblastic Tumor: Epithelioid Trophoblastic Tumor With No Evidence Of Metastasis, Epithelioid Trophoblastic Tumor With Metastasis
5) By Other Types: Trophoblastic Tumor Of Unknown Origin, Non-Gestational Trophoblastic Neoplasia
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Novartis AG, Merck And Co. Inc., Sun Pharmaceutical Industries Ltd., GSK plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Mylan N.V, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Perrigo Company plc, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., Wockhardt Ltd., Natco Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Arog Pharmaceuticals Inc., Advenchen Laboratories LLC., Mendus AB, AB Science S.A.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Gestational Trophoblastic Disease Market Characteristics

3. Gestational Trophoblastic Disease Market Trends And Strategies

4. Gestational Trophoblastic Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gestational Trophoblastic Disease Growth Analysis And Strategic Analysis Framework

5.1. Global Gestational Trophoblastic Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gestational Trophoblastic Disease Market Growth Rate Analysis

5.4. Global Gestational Trophoblastic Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gestational Trophoblastic Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gestational Trophoblastic Disease Total Addressable Market (TAM)

6. Gestational Trophoblastic Disease Market Segmentation

6.1. Global Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hydatidiform Mole

Choriocarcinoma

Placental-Site Trophoblastic Tumor

Epithelioid Trophoblastic Tumor

Other Types

6.2. Global Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgery

Chemotherapy

Suction Dilation And Curettage (D&C)

Radiation Therapy

6.3. Global Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital And Clinics

Diagnostic Centers

Other End Users

6.4. Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Hydatidiform Mole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Complete Hydatidiform Mole

Partial Hydatidiform Mole

6.5. Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Choriocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Metastatic Choriocarcinoma

Metastatic Choriocarcinoma

6.6. Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Placental-Site Trophoblastic Tumor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

PSTT With Normal Placentation

PSTT With Abnormal Placentation

6.7. Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Epithelioid Trophoblastic Tumor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Epithelioid Trophoblastic Tumor With No Evidence Of Metastasis

Epithelioid Trophoblastic Tumor With Metastasis

6.8. Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Trophoblastic Tumor Of Unknown Origin

Non-Gestational Trophoblastic Neoplasia

7. Gestational Trophoblastic Disease Market Regional And Country Analysis

7.1. Global Gestational Trophoblastic Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gestational Trophoblastic Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gestational Trophoblastic Disease Market

8.1. Asia-Pacific Gestational Trophoblastic Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gestational Trophoblastic Disease Market

9.1. China Gestational Trophoblastic Disease Market Overview

9.2. China Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gestational Trophoblastic Disease Market

10.1. India Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gestational Trophoblastic Disease Market

11.1. Japan Gestational Trophoblastic Disease Market Overview

11.2. Japan Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gestational Trophoblastic Disease Market

12.1. Australia Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gestational Trophoblastic Disease Market

13.1. Indonesia Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gestational Trophoblastic Disease Market

14.1. South Korea Gestational Trophoblastic Disease Market Overview

14.2. South Korea Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gestational Trophoblastic Disease Market

15.1. Western Europe Gestational Trophoblastic Disease Market Overview

15.2. Western Europe Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gestational Trophoblastic Disease Market

16.1. UK Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gestational Trophoblastic Disease Market

17.1. Germany Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gestational Trophoblastic Disease Market

18.1. France Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gestational Trophoblastic Disease Market

19.1. Italy Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gestational Trophoblastic Disease Market

20.1. Spain Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gestational Trophoblastic Disease Market

21.1. Eastern Europe Gestational Trophoblastic Disease Market Overview

21.2. Eastern Europe Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gestational Trophoblastic Disease Market

22.1. Russia Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gestational Trophoblastic Disease Market

23.1. North America Gestational Trophoblastic Disease Market Overview

23.2. North America Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gestational Trophoblastic Disease Market

24.1. USA Gestational Trophoblastic Disease Market Overview

24.2. USA Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gestational Trophoblastic Disease Market

25.1. Canada Gestational Trophoblastic Disease Market Overview

25.2. Canada Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gestational Trophoblastic Disease Market

26.1. South America Gestational Trophoblastic Disease Market Overview

26.2. South America Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gestational Trophoblastic Disease Market

27.1. Brazil Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gestational Trophoblastic Disease Market

28.1. Middle East Gestational Trophoblastic Disease Market Overview

28.2. Middle East Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gestational Trophoblastic Disease Market

29.1. Africa Gestational Trophoblastic Disease Market Overview

29.2. Africa Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gestational Trophoblastic Disease Market Competitive Landscape And Company Profiles

30.1. Gestational Trophoblastic Disease Market Competitive Landscape

30.2. Gestational Trophoblastic Disease Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Gestational Trophoblastic Disease Market Other Major And Innovative Companies

31.1. Merck And Co. Inc.

31.2. Sun Pharmaceutical Industries Ltd.

31.3. GSK plc

31.4. Bristol-Myers Squibb Company

31.5. Sanofi S.A.

31.6. AstraZeneca plc

31.7. Eli Lilly and Company

31.8. Mylan N.V

31.9. Daiichi Sankyo Co. Ltd.

31.10. Eisai Co. Ltd.

31.11. Perrigo Company plc

31.12. Jiangsu Hengrui Medicine Co. Ltd.

31.13. Exelixis Inc.

31.14. Wockhardt Ltd.

31.15. Natco Pharma Ltd.

32. Global Gestational Trophoblastic Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gestational Trophoblastic Disease Market

34. Recent Developments In The Gestational Trophoblastic Disease Market

35. Gestational Trophoblastic Disease Market High Potential Countries, Segments and Strategies

35.1 Gestational Trophoblastic Disease Market In 2029 - Countries Offering Most New Opportunities

35.2 Gestational Trophoblastic Disease Market In 2029 - Segments Offering Most New Opportunities

35.3 Gestational Trophoblastic Disease Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Hydatidiform Mole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Choriocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Placental-Site Trophoblastic Tumor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Epithelioid Trophoblastic Tumor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Gestational Trophoblastic Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Gestational Trophoblastic Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: F. Hoffmann-La Roche AG Financial Performance
  • Table 81: AbbVie Inc. Financial Performance
  • Table 82: Bayer AG Financial Performance
  • Table 83: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Hydatidiform Mole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Choriocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Placental-Site Trophoblastic Tumor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Epithelioid Trophoblastic Tumor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Gestational Trophoblastic Disease Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Gestational Trophoblastic Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Gestational Trophoblastic Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: F. Hoffmann-La Roche AG Financial Performance
  • Figure 81: AbbVie Inc. Financial Performance
  • Figure 82: Bayer AG Financial Performance
  • Figure 83: Novartis AG Financial Performance

Strong CAGR to Propel in the Central Nervous System Lymphoma Treatment Market and Beyond upto $1.66 Billion by 2029

Read More About Strong CAGR to Propel in the Central Nervous System Lymphoma Treatment Market and Beyond upto $1.66 Billion by 2029

Cerebral Adrenoleukodystrophy (CALD) Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Cerebral Adrenoleukodystrophy (CALD) Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Cerebral Amyloid Angiopathy Treatment Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Cerebral Amyloid Angiopathy Treatment Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Chikungunya Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Chikungunya Market Trends: Regional Breakdowns and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Medical Equipment Market 2024 – By Type (In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic De...

View Report

Parenting Apps Global Market Report 2025 – By Type (Pregnancy Tracker Apps, Baby Tracker Apps, Co-parenting Apps, Baby Care Apps), By App Features (Nutrition Advice, Sleep Management, Developmental Milestones, Health Con...

View Report

Fetal Bovine Serum Global Market Report 2025 – By Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products), By Application (Drug Discovery, Cell Culture Media...

View Report

Smart Spraying Technology Global Market Report 2025 – By Mobility (Mounted, Self-Propelled, Trailed), By Farm Size (Small-Sized Farms, Large-Sized Farms), By Application (Row Crops, Arboriculture, Viticulture, Horticultu...

View Report

Signal Conditioning Modules Global Market Report 2025 – By Type (Temperature Input, Process Input, Frequency Input, LVDT (Linear Variable Differential Transformer) Or RVDT (Rotary Variable Differential Transformer)), By ...

View Report

Serine Proteases Global Market Report 2025 – By Type (C1R, C1S, C3A, C3B), By Application (Digestive System, Blood Coagulation System, Complement System, Other Applications), By End-Use (Dietary Supplements, Nutraceutica...

View Report

Ethyl Cellulose Global Market Report 2025 – By Type (Cosmetic Grade, Food Grade, Industrial Grade, Pharmaceutical Grade), By Source (Cotton, Wood Pulp), By Application (Personal Care and Cosmetic, Food, Pharmaceuticals, ...

View Report

Data Analytics Global Market Report 2025 – By Type (Big Data Analytics, Business Analytics, Customer Analytics, Risk Analytics, Statistical Analysis, Other Types), By Deployment (On-Premises, Cloud), By Enterprise Size (...

View Report

Frequently Asked Questions

Gestational trophoblastic disease (GTD) refers to a group of rare and abnormal conditions that develop from the abnormal growth of trophoblastic cells that develop a tumor inside the uterus after conception. The treatment of GTD involves uterine evacuation and monitoring human chorionic gonadotropin (hCG) levels. For further insights on this market, request a sample here

The market major growth driver - Rising Incidence Of Abnormal Pregnancies Fuels Growth In The Gestational Trophoblastic Disease Market. For further insights on this market, request a sample here

The gestational trophoblastic disease market size has grown steadily in recent years. It will grow from $2.06 billion in 2024 to $2.16 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to public health initiatives, improved understanding of disease pathology, medical research and clinical trials, development of targeted therapies, shift in treatment protocols. The gestational trophoblastic disease market size is expected to see strong growth in the next few years. It will grow to " $2.63 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to healthcare infrastructure development, enhanced telemedicine and remote care, patient-centric care approaches, regulatory approvals for novel treatments, genomic and molecular studies. Major trends in the forecast period include shift towards personalized medicine, advancements in molecular diagnostics, focus on immunotherapies and targeted therapies, integration of digital health technologies, rising awareness and education programs. For further insights on this market, request a sample here

The gestational trophoblastic diseasemarket covered in this report is segmented –
1) By Type: Hydatidiform Mole; Choriocarcinoma; Placental-Site Trophoblastic Tumor; Epithelioid Trophoblastic Tumor; Other Types
2) By Treatment: Surgery; Chemotherapy; Suction Dilation And Curettage (D&C); Radiation Therapy
3) By End User: Hospital And Clinics; Diagnostic Centers; Other End Users Subsegments:
1) By Hydatidiform Mole: Complete Hydatidiform Mole; Partial Hydatidiform Mole
2) By Choriocarcinoma: Non-Metastatic Choriocarcinoma; Metastatic Choriocarcinoma
3) By Placental-Site Trophoblastic Tumor: PSTT With Normal Placentation; PSTT With Abnormal Placentation
4) By Epithelioid Trophoblastic Tumor: Epithelioid Trophoblastic Tumor With No Evidence Of Metastasis; Epithelioid Trophoblastic Tumor With Metastasis
5) By Other Types: Trophoblastic Tumor Of Unknown Origin; Non-Gestational Trophoblastic Neoplasia For further insights on this market, request a sample here

Asia-Pacific was the largest region in the gestational trophoblastic disease market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational trophoblastic disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the gestational trophoblastic disease market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Novartis AG, Merck And Co. Inc., Sun Pharmaceutical Industries Ltd., GSK PLC, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Mylan N.V, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Perrigo Company PLC, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., Wockhardt Ltd., Natco Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Arog Pharmaceuticals Inc., Advenchen Laboratories LLC., Mendus AB, AB Science S.A.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Guidelines Enhance Care In The Gestational Trophoblastic Disease Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Gestational Trophoblastic Disease Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon